New use for cannabinoid-containing plant extracts (Brevetto)

Type
Label
  • New use for cannabinoid-containing plant extracts (Brevetto) (literal)
Anno
  • 2008-01-01T00:00:00+01:00 (literal)
Alternative label
  • De Petrocellis Luciano, Di Marzo Vincenzo, Schiano Moriello Aniello (2008)
    New use for cannabinoid-containing plant extracts
    (literal)
Titolo
  • New use for cannabinoid-containing plant extracts (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • De Petrocellis Luciano, Di Marzo Vincenzo, Schiano Moriello Aniello (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#altreInformazioni
  • Also published as CN101678059A, EP2146731A1, US20100249223, WO2008129258A1 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#proprieta
  • De Petrocellis Luciano, Di Marzo Vincenzo, GW Pharma Ltd, Schiano Moriello Aniello (literal)
Http://www.cnr.it/ontology/cnr/brevetti.owl#tipoDiBrevetto
  • Internazionale (literal)
Numero brevetto
  • CA2684562 A1 (literal)
Anno di deposito
  • 2008 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Endocannabinoid Research Group: Istituto di Cibernetica e Istituto di Chimica Biomolecolare, CNR (literal)
Titolo
  • New use for cannabinoid-containing plant extracts (literal)
Http://www.cnr.it/ontology/cnr/brevetti.owl#annoDiConcessione
  • 2008 (literal)
Abstract
  • The present invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of diseases or conditions that are alleviated by blockade of one or more types of TRP channel. Preferably the subset of TRP channel that is blockaded is the TRPA channel. More preferably the TRPA channel is the TRPA1 channel. Preferably the diseases or conditions to be prevented or treated include: neuropathic pain, inflammation or vasoconstriction. Alternatively the TRP channel that is blockaded is the TRPM channel. More preferably the TRPM channel is the TRPM8 channel. Preferably the diseases or conditions to be prevented or treated are cancer. More preferably the cancers to be treated include: cancer of the prostate, cancer of the breast, cancer of the colon, cancer of the lung or cancer of the skin. Alternatively the TRP channel that is blockaded is the TRPV channel. More preferably the TRPV channel is the TRPV1 channel. Preferably the diseases or conditions to be prevented or treated include neuropathic pain, inflammation or vasoconstriction. (literal)
Prodotto di
Autore CNR

Incoming links:


Prodotto
Autore CNR di
data.CNR.it